Home Bio Usawa

Bio Usawa

In operation
-
Monoclonal Antibody Developer
Basic
Enterprise Profile

Basic Information

Bio Usawa Inc. is a privately held biotechnology company dedicated to developing and producing high-quality, affordable, life-saving monoclonal antibodies in Africa, serving patients in Africa and beyond.
Bio Usawa Inc.
Rwanda
less than 15 people
February 01, 2024
info@biousawa.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs Monoclonal Antibody